We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

158 hedge funds and large institutions have $830M invested in Aerie Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 61 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 19

38% more capital invested

Capital invested by funds: $601M → $830M (+$229M)

5% more funds holding

Funds holding: 150 → 158 (+8)

25% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 61

25% less call options, than puts

Call options by funds: $3.8M | Put options by funds: $5.06M

Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
46
Reduced
61
Closed
19
Calls
$3.8M
Puts
$5.06M
Net Calls
-$1.26M
Net Calls Change
-$2.71M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$37.3M
2
GIM
Granahan Investment Management
Massachusetts
+$14.3M
3
Principal Financial Group
Principal Financial Group
Iowa
+$9.14M
4
RCMNY
Rubric Capital Management (New York)
New York
+$8.3M
5
ACM
Atika Capital Management
New York
+$8.29M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11.5M
2
VOYA Investment Management
VOYA Investment Management
Georgia
-$7.87M
3
First Manhattan
First Manhattan
New York
-$6.14M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$5.91M
5
Bank of America
Bank of America
North Carolina
-$5.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
151
Harbour Investments
Wisconsin
$3K +$3.02K +175 New
Daiwa Securities Group
152
Daiwa Securities Group
Japan
$2K – – –
PNC Financial Services Group
153
PNC Financial Services Group
Pennsylvania
$2K – – –
SFS
154
Sowell Financial Services
Arkansas
$2K – – –
WAP
155
Wealthcare Advisory Partners
Pennsylvania
$2K +$2.16K +125 New
APA
156
American Portfolios Advisors
New York
$1.79K +$691 +40 +67%
AIG
157
American International Group
New York
$382 +$985 +57 +0.3%
Nisa Investment Advisors
158
Nisa Investment Advisors
Missouri
$13 – – –
First Manhattan
159
First Manhattan
New York
– -$6.14M -454,216 Closed
Alyeska Investment Group
160
Alyeska Investment Group
Illinois
– -$2.79M -206,551 Closed
Walleye Capital
161
Walleye Capital
New York
– -$1.05K -77,800 Closed
TCM
162
Tekla Capital Management
Massachusetts
– -$901K -66,688 Closed
Squarepoint
163
Squarepoint
New York
– -$695K -51,417 Closed
Man Group
164
Man Group
United Kingdom
– -$586K -43,400 Closed
Wellington Management Group
165
Wellington Management Group
Massachusetts
– -$418K -31,025 Closed
HSBC Holdings
166
HSBC Holdings
United Kingdom
– -$302K -22,407 Closed
CWM
167
Circle Wealth Management
New Jersey
– -$260K -19,240 Closed
Invesco
168
Invesco
Georgia
– -$233K -17,197 Closed
Los Angeles Capital Management
169
Los Angeles Capital Management
California
– -$215K -15,885 Closed
IA
170
IndexIQ Advisors
New York
– -$210K -15,515 Closed
WMSA
171
Weiss Multi-Strategy Advisers
New York
– -$141K -10,452 Closed
WCM
172
Weld Capital Management
New York
– -$136K -10,063 Closed
AA
173
AlphaCentric Advisors
Puerto Rico
– -$54K -4,000 Closed
WC
174
Wexford Capital
Florida
– -$42K -3,101 Closed
GC
175
Grace Capital
Massachusetts
– -$14K -1,000 Closed
4 5 6
7
8

AERI Hedge Fund Activity: Q1 2021 in Review

158 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2021, worth a combined $830M — up 38% from $601M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AERI positions and 19 closed out — a net gain of 9 holders — while 46 added to existing stakes and 61 trimmed.

The largest buyer was Woodline Partners, opening a new position worth an estimated $37.3M. The largest seller was Deerfield Management, cutting an estimated $11.5M.

  • 158 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2021, up from 150 in Q4 2020.
  • Funds reported $830M of Aerie Pharmaceuticals stock for Q1 2021, up 38% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q1 2021 and 19 closed out, a net change of +9 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2021 was Woodline Partners, an estimated $37.3M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2021 was Deerfield Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q1 2021.